Get a never before seen look at the chronic myeloid leukemia (CML) program in Tanzania! Over 20 years ago, we partnered with local healthcare professionals to provide treatment access for people living with cancer – at no cost to them, for as long as they need
it.
Africa Region Head Cathy Scheepers takes you to clinics in Moshi and Dar es Salaam, talking with patients, advocates, and physicians about their progress and how we can reach more people living with CML.
Stay tuned for more behind-the-scenes videos! Cathy and the Max team will be visiting several countries this year, including Lesotho, Kenya, Malawi, Sierra Leone, and Ethiopia.
Join our email list for updates and follow along on social media to join the conversation.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
When someone facing cancer gains access to treatment, they gain access to life. With oral chemotherapies, access to treatment isn’t simply a one-time occurrence. Each and every day, tens of thousands of cancer patients take life-saving medication they receive free-of-cost – all thanks to the unseen work of partners, donors, and Max team members.
For the 20th anniversary of World Cancer Day, we asked our global team members, physicians, patients, caregivers, and advocates to share what progress in cancer care means to them. Progress means all cancer patients get the treatment they deserve.[/e World Cancer Day, celebrated on February 4, is a global initiative that aims to raise awareness….
A “cold-chain” product must remain within a specific temperature range at all times. On days- or weeks-long international shipments, it’s especially challenging (and expensive) to keep medicine at a constant temperature. Despite the inherent challenges, adding cold-chain capability is well worth the effort for the patients we support. By doing so, The Max Foundation will be able to better meet the needs of patients who are unresponsive to tablet therapies.
